Abstract:Objective To assess the efficacy and safety of S-amlodipine versus amlodipine,and 2.5mg S-amlodipine versus 5.0mg S-amlodipine in treating hypertension.Methods Medline,Embase,CENTRAL,ClinicalTrials.gov,China National Knowledge Infrastructure,WanFang Data and VIP databases were searched for randomized controlled trials(RCTs)about S-amlodipine for hypertension till January 2018.Two reviewers independently reviewed the literature,extracted data and assessed the risk of bias of included RCTs.RevMan 5.3 software was used for meta-analysis.Results All together 16 RCTs involving 3946 patients were included.The results of meta-analysis showed that:(1)S-amlodipine vs.amlodipine:the levels of reduction in intima-media thickness [mean difference(MD)=–0.21mm,95% confidence interval(CI)(–0.35,–0.07)mm,P=0.003],pulse pressure [MD=–5.90mmHg(1mmHg=0.133kPa),95%CI(–8.57,–3.23)mmHg,P<0.0001],systolic pressure [MD=–5.08mmHg,95%CI(–9.61,–0.55)mmHg,P=0.03],and diastolic pressure [MD=–4.60mmHg,95%CI(–7.82,–1.39)mmHg,P=0.005]were all higher in the S-amlodipine group than in the amlodipine group,and the incidence of adverse event [relative risk=0.55,95%CI(0.40,0.77),P=0.0004]was lower in the S-amlodipine group.But no significant differences were found in changes of left ventricular posterior wall thickness,heart rate,blood pressure variability between the two groups.(2)2.5mg S-amlodipine vs.5.0mg S-amlodipine:the levels of reduction in systolic pressure [MD=4.17mmHg,95%CI(2.23,6.11)mmHg,P<0.0001]and diastolic pressure [MD=1.84mmHg,95%CI(1.17,2.52)mmHg,P<0.00001]were higher in the 5.0mg S-amlodipine group than in the 2.5mg S-amlodipine group,but no significant difference was found in the incidence of adverse event between the two groups.None of the primary outcomes was analyzed because they were not reported by any one of the included studies.Conclusion Current evidence shows that S-amlodipine is slightly superior to amlodipine in reducing intimameida thickness which could indirectly reflect the effect of interventions on endpoint outcome measures,blood pressure,pulse pressure,and the incidence of adverse event.5.0mg S-amlodipine is slightly superior to 2.5mg S-amlodipine in reducing blood pressure,though comparable with the latter in the effect on incidence of adverse event.The effect of S-amlodipine on all the primary outcomes is unclear because none of the included studies reported on those.Due to limited quantity and quality of the included studies,more high quality studies are needed to verify the above conclusions.

Clinical Efficacy Analysis of Amlodipine in the Treatment of Primary Hypertension

Effects of Atenolol and Diltiazem-Sr on Quality of Life in the Hypertensive Patients

The Effectiveness and Safety of L-amlodipine Besylate for Blood Pressure Control in Patients with Mild to Moderate Essential Hypertension

The Efficacy and Safety of Amlodipine Maleate on Patients with Mild to Moderate Essential Hypertension

Efficacy and Safety of Generic and Patented Amlodipine for Hypertension:A Meta-Analysis

Efficacy and safety of amlodipine plus captopril for the treatment of essential hypertension:A Meta-analysis

Meta-analysis of the Efficacy and Safety of Benazepril vs. Captopril in the Treatment of Primary Hypertension

Meta-analysis of Effectiveness and Safety of Levoamlodipine and Amlodipine for Essential Hypertension

Efficacy and Safety of S-Amlodipine versus other antihypertensive drugs for Hypertension: A Systematic Review and Meta-analysis

Comparative Study for Antihypertensive Effect and Impact on Vascular Endothelial Function in Hypertension Patients between Amlodipine and Levamlodipine

Effects of Amlodipine Plus Telmisartan or Amlodipine Plus Amiroride Regimen on Blood Pressure Control in Hypertensive Patients:Preliminary Report of Chinese Hypertension Intervention Efficacy (Chief)trial

Clinical effect and safety of nifedipine controlled-release tablets combined with valsartan in the treatment of primary hypertension

Efficacy and safety of S-amlodipine versus amlodipine and 2.5mg S-amlodipine versus 5.0mg S-amlodipine for hypertension:a systematic review and meta-analysis

PS 14-31 AMBULATORY BLOOD PRESSURE LOWERING EFFICACY AND TOLERABILITY OF INITIAL HIGH DOSE OF AMLODIPINE IN MILD OR MODERATE HYPERTENSION

A Clinical Trial Comparing the Efficacy and Safety of Cilnidipine Capsules Versus Cilnidipine Tablets in Patients with Mild and Moderate Primary Hypertension

The Comparative Study for The Clinical Treatment Effect of Different Treatment Methods in the Treatment of Hypertensive Patients with Coronary Heart Disease

Efficacy and Safety of Olmesartan Medoxomil-Amlodipine Besylate Tablet in Chinese Patients with Essential Hypertension: A Prospective, Single-Arm, Multi-Center, Real-World Study

A5504 Comparison of the Effects of Valsartan and Amlodipine on the Characteristics of Ambulatory Blood Pressure in Hypertensive Patients

Systematic Review of Therapeutic Efficacy and Safety of Enalapril in the Treatment of Essential Hypertension

A meta-analysis of anti-hypertensive efficacy and safety between cilnidipine and amlodipine

Efficacy and Safety of Fixed Compound Amlodipine and Atorvastatin in Patients with Hypertension Accompanying Hyperlipidemia